SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-09-000069
Filing Date
2009-01-06
Accepted
2009-01-06 16:01:32
Documents
4
Period of Report
2008-12-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ALSERES PHARMACEUTICALS, INC. b73510ape8vk.htm 8-K 17543
2 EX-10.1 AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED DECEMBER 31, 2008, BETW b73510apexv10w1.htm EX-10.1 64915
3 EX-10.2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED DECEMBER 31, 2008, BETW b73510apexv10w2.htm EX-10.2 64747
4 EX-10.3 AMENDED AND RESTATED EMPLOYMENT AGREEMENT, DATED DECEMBER 31, 2008, BETW b73510apexv10w3.htm EX-10.3 64959
  Complete submission text file 0000950135-09-000069.txt   214048
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-06533 | Film No.: 09510007
SIC: 2834 Pharmaceutical Preparations